Avience Biomedicals Limited

Avience Biomedicals Limited

SMEClosed

₹2,49,600(1,200 Shares)

Minimum Investment

IPO Dates

Jun 18, 2026 – Jun 22, 2026

Price Band

₹196–208 per equity share

Lot Size

600

Listing

Jun 25, 2026

Listing At

NSE SME

Jun 18, 2026Open DateCompleted
Jun 22, 2026Close DateCompleted
TBAAllotment DateUpcoming
Jun 25, 2026Listing DateCompleted

Avience Biomedicals Limited Live Subscription Details

All IPOs
QIB / NII0.00x
QIB196.77x
Retail401.21x
NIIs
597.62x

NII Sub-Categories

bHNI (> ₹10L)

Bids above ₹10L

670.77x

sHNI (< ₹10L)

Bids ₹2L to ₹10L

451.32x

Overall Subscription

Total Bids Received

385.33x

Avience Biomedicals Limited IPO Issue Details

Issue Price
₹196-208 Per Equity Share
Face Value
₹10 Per Equity Share
Fresh Share
14,53,800 shares(aggregating up to ₹30.24 crore)
Listing At
NSE SME
Listing Date
Jun 25, 2026
Registrar
Skyline Financial Services Private Ltd

Market Lot Details

CategoryLotsSharesAmount
Retail (Min)21,200₹2,49,600
Retail (Max)21,200₹2,49,600
sHNI (Min)31,800₹3,74,400
sHNI (Max)84,800₹9,98,400
bHNI (Min)95,400₹11,23,200

Reservation Details

NII14.24%

Shares Offered

2,07,000

QIB18.82%

Shares Offered

2,73,600

Anchor28.19%

Shares Offered

4,09,800

Individual33.1%

Shares Offered

4,81,200

Market Maker5.65%

Shares Offered

82,200

Company Information

Incorporatedin June 2024, Avience Biomedicals Limited is an ISO-certified company involved in the manufacture, supply, and export of molecular diagnostics solutions, with an emphasis on biotechnology,...

Valuations

EPS (Pre-IPO)

17.94

EPS (Post-IPO)

12.56

P/E (Pre-IPO)

11.59

P/E (Post-IPO)

16.56

RoNW

22.38%

P/B Value

2.94

Market Cap

₹114.09 Cr.

Financial Information (₹ in Crores)

MetricFY 26FY 25FY 24
Total Assets51.9643.625.63
Total Revenue28.8529.5416.64
Profit After Tax4.185.141.98
Net Worth24.720.526.05

* All figures are in ₹ Crores unless otherwise stated.

Objectives of the Issue

  1. 1Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh
  2. 2Funding the working capital requirements of the Company
  3. 3General corporate purposes

Avience Biomedicals Limited – Promoter(s)

Mr. Dharam Deo Choudhary
Mr. Ram Nagina Choudhary
Mr. Janardan Pal
Ms. Deepa Choudhary

Contact Details

Corporate Office

C-11, Block-C, Community Centre, Janakpuri A-3, New Delhi - 110058.

1800-12-04-636

info@avienbio.com

Visit Website

Avience Biomedicals Limited Allotment & Registrar Details

Check Allotment

Skyline Financial Services Private Ltd

02228511022

ipo@skylinerta.com

Visit Registrar Website

Avience Biomedicals Limited IPO Documents

Frequently Asked Questions — Avience Biomedicals Limited IPO

The Avience Biomedicals Limited IPO price band is set at ₹196.00 to ₹208.00 per equity share.

The lot size for Avience Biomedicals Limited IPO is 600 shares per lot. The minimum investment amount is approximately ₹1,24,800.

The Avience Biomedicals Limited IPO opens on Jun 18, 2026 and closes on Jun 22, 2026.

Avience Biomedicals Limited IPO is expected to be listed on Jun 25, 2026 on NSE SME.

The current GMP for Avience Biomedicals Limited IPO is ₹100, suggesting an expected listing price of around ₹296.00. Note: GMP is an unofficial market indicator.

The registrar for Avience Biomedicals Limited IPO is Skyline Financial Services Private Ltd. You can contact them at ipo@skylinerta.com.

View All
ESDS Software Solution

ESDS Software Solution

LiveMainboard
GMP +335

Price Band: 408–₹429

Lumino Industries

Lumino Industries

LiveMainboard
GMP +50

Price Band: 78–₹82

Kwick Forensic Solutions

Kwick Forensic Solutions

LiveSME
GMP +44

Price Band: 85–₹90

Deepa Jewellers

Deepa Jewellers

UpcomingMainboard
GMP +38

Price Band: 168–₹177

Priority Jewels

Priority Jewels

LiveMainboard
GMP +31

Price Band: 190–₹200

Paluck Technologies

Paluck Technologies

LiveSME
GMP +12

Price Band: 46–₹48